Search

everythinglearnresearchcommunity

for

Search:↓

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Formalin-induced pain increases testosterone breakdown in the rat brain and spinal cord.

Botulinum toxin is a safe alternative for treating migraines without common side effects, but should be used after other treatments fail.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Both enzyme forms can sulfate minoxidil.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Polymeric nanoparticles show promise for treating skin diseases.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.